Asthma

Asthma can be unpredictable and can limit many aspects of your life from physical activity to work, school, and time spent with friends and family. Some 25 million Americans have asthma and 5%-10% of these patients are diagnosed with severe asthma.
Learn more about severe asthma at BTforAsthma.com »
Image of people hiking

If severe asthma has you struggling to breathe, Bronchial Thermoplasty (BT) may be an option

Image showing BT clinical study results
As with any procedure, there are risks, and individual results may vary. The most common side effect of BT is temporary worsening of respiratory-related symptoms. This side effect typically occurs within a day of the procedure and resolves within 7 days on average with standard care. There is a small (3.4% per procedure) risk of these symptoms requiring hospitalization.
What happens during an Asthma Attack
BT is a revolutionary approach to treating patients with severe asthma who are on high doses of medication and still have symptoms. BT actually reduces the amount of excess smooth-muscle tissue in the airways — the airways constrict less, breathing is easier, and there is less likelihood of an asthma attack.
References
† Cox, et al. Eur Respir J. 2004. 24:659-663. 1. Castro M, et al. Ann Allergy Asthma Immunol. 2011;107:65-70. 2. Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124. 3. Woodruff PG, et al. Am J Respir Crit Care Med. 2004;169:1001-1006. 4. Cox PG, et al. Eur Respir J. 2004;24:659-663. 5. Wechsler ME. Allergy Asthma Proc. 2008;29:1-6.
Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms. ENDO-551804-AA